Intrinsiqs

Is Haemonetics Corporation overvalued?

Haemonetics Corporation (HAE) looks undervalued — trading about 45% below its fair value.

Undervalued
Current price $90.38 Fair value $131.01
Price
$90.38
Fair value
$131.01
Current P/E
18.2
Normal P/E
26.4
Market cap
$4.11B
Dividend yield
0.0%
Return on equity
11.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares HAE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.